
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
about 29 years ago
Postpartum Depressionabout 29 years ago
Pharmaceutical Considerations of Common Herbal Medicineabout 29 years ago
When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?about 29 years ago
Treatment Patterns for Heart Failure in a Primary Care Environmentabout 29 years ago
Enhancement of Compliance Among Patients with Hypertension




